BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9355880)

  • 21. Studies on biochemical markers in cryoinfarction in rats.
    Hemalatha T; Mala VV; Manohar BM; Nayeem M; Subramaniam S; Puvanakrishnan R
    Cryo Letters; 2006; 27(5):311-8. PubMed ID: 17256064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impacts of type 2 diabetes mellitus on bone markers in the elderly Thai women.
    Pooruk P; Kittimanon N; Janthorn P; Bunyaratavej N
    J Med Assoc Thai; 2009 Sep; 92 Suppl5():S45-8. PubMed ID: 19891380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in markers of bone collagen turnover in toxic and euthyroid states: a study of 22 patients.
    Wilkinson H; Horsely E
    Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():454-5. PubMed ID: 8888980
    [No Abstract]   [Full Text] [Related]  

  • 24. Time course of plasma markers of collagen turnover in patients with acute myocardial infarction.
    McGavigan AD; Moncrieff J; Lindsay MM; Maxwell PR; Dunn FG
    Heart; 2004 Sep; 90(9):1053-4. PubMed ID: 15310700
    [No Abstract]   [Full Text] [Related]  

  • 25. A biomarker of myocardial fibrosis predicts long-term response to cardiac resynchronization therapy.
    García-Bolao I; Macías A; López B; González A; Gavira JJ; Azcárate P; Alegría E; Díez J
    J Am Coll Cardiol; 2006 Jun; 47(11):2335-7. PubMed ID: 16750706
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for an acute rise of intestinal calcium absorption in response to aerobic exercise.
    Zittermann A; Sabatschus O; Jantzen S; Platen P; Danz A; Stehle P
    Eur J Nutr; 2002 Oct; 41(5):189-96. PubMed ID: 12395212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease.
    López B; González A; Querejeta R; Díez J
    J Hypertens; 2005 Aug; 23(8):1445-51. PubMed ID: 16003166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagen propeptides as indicators of collagen assembly.
    Risteli J; Niemi S; Kauppila S; Melkko J; Risteli L
    Acta Orthop Scand Suppl; 1995 Oct; 266():183-8. PubMed ID: 8553849
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fibrosis biomarkers procollagen type III, N-terminal propeptide and transforming growth factor β1 as foes for patients with atrial fibrillation.
    Tao H; Cao W; Shi KH
    Am Heart J; 2014 Oct; 168(4):e15. PubMed ID: 25262272
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
    Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
    Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
    Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limiting fibrosis after myocardial infarction.
    Jugdutt BI
    N Engl J Med; 2009 Apr; 360(15):1567-9. PubMed ID: 19357414
    [No Abstract]   [Full Text] [Related]  

  • 34. Diurnal variations in serum and urine markers of type I and type III collagen turnover in children.
    Wolthers OD; Heuck C; Heickendorff L
    Clin Chem; 2001 Sep; 47(9):1721-2. PubMed ID: 11514416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Advances in study of biomarkers of myocardial fibrosis].
    Wang YP; Xu M; Gao W
    Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):461-3. PubMed ID: 21416968
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical diagnosis of left ventricular remodelling in refractory hypertension].
    Díez J
    Med Clin (Barc); 2012 Feb; 138(4):155-6. PubMed ID: 21939997
    [No Abstract]   [Full Text] [Related]  

  • 37. Monitoring fibrillar collagen turnover in hypertensive heart disease.
    Díez J; Laviades C
    Cardiovasc Res; 1997 Aug; 35(2):202-5. PubMed ID: 9349382
    [No Abstract]   [Full Text] [Related]  

  • 38. A study on myocardial fibrosis in myocardial infarction and in idiopathic cardiomyopathy: a measurement of hydroxyproline level in plasma and in myocardium.
    Takahashi S
    Jpn Circ J; 1979 Oct; 43(10):913-21. PubMed ID: 513264
    [No Abstract]   [Full Text] [Related]  

  • 39. Unravelling the mysteries of collagen and cicatrix after myocardial infarction.
    Whittaker P
    Cardiovasc Res; 1995 Jun; 29(6):758-62. PubMed ID: 7656278
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of serum concentration of connective tissue components in cases of organic fibroses].
    Kropf J; Gressner AM
    Z Med Lab Diagn; 1991; 32(3-4):150-8. PubMed ID: 1897291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.